TED clinical trials at UCSD

1 in progress, 0 open to eligible people

Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
Sorry, in progress, not accepting new patients
The purpose of this study is to assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of subcutaneous (SC) satralizumab, a recombinant, humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, in participants with thyroid eye disease (TED).
La Jolla, California and other locations

Last updated: February 19, 2025